 Nonpeptide angiotensin II receptor antagonists direct way renin-angiotensin system RAS level angiotensin II AII receptor available AII receptor antagonists peptides significant agonistic properties obvious drawbacks limited stability lack oral activity simple N-benzylimidazoles weak selective AII receptor antagonists competitive mode action Chemical modification early leads affinity Oral activity particular class compounds displaces specific binding sites various tissues AII-induced responses various vitro vivo preparations AII-induced responses KCl norepinephrine vasopressin enzyme renin high renin models elevated blood pressure renal hypertensive rat sodium-depleted dog substances sustained decrease arterial pressure heart rate intravenous oral administration None compounds agonistic activity test systems conclusion nonpeptide structures herein selective competitive AII receptor antagonists dimension arsenal drugs RAS